The pharmacology of GPR55 and its potential role in cancer
In a recent patent, GPR55 emerged as a novel target for cannabinoid modulation, and was found to be activated by a number of synthetic and endogenous cannabinoids, including anandamide, virodhamine, and AM251. There is mounting evidence to suggest that cannabinoids play a role in tumour progression...
| Main Author: | |
|---|---|
| Published: |
University of Aberdeen
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.510551 |